PLRX

NASDAQStock

Pliant Therapeutics, Inc.

$1.34-0.07 (-4.61%)

52-Week Range

$1.09
$1.87

Key Stats

Market Cap

82.6M

P/E Ratio

Dividend Yield

Beta

1.28

Volume

578.2K

Avg Volume

504.2K

Performance

1M

+24.78%

3M

+13.71%

6M

-7.84%

YTD

+12.80%

1Y

-8.44%

3Y

-94.88%

5Y

-96.31%

Price Chart

ETF Exposure

PLRX is held by 11 ETFs

ETFFund NameWeight
IWCiShares Micro-Cap ETF0.01%
NUSCNuveen ESG Small-Cap0.01%
PRFZInvesco RAFI US 1500 Small-Mid ETF0.01%
VHTVanguard Health Care ETF0.00%
VXFVanguard Extended Market ETF0.00%
VCNS.TOVanguard Conservative ETF Portfolio0.00%
VEQT.TOVanguard All-Equity ETF Portfolio0.00%
VRIF.TOVanguard Retirement Income ETF Portfolio0.00%
VTIVanguard Total Stock Market ETF0.00%
VUN.TOVanguard U.S. Total Market Index ETF0.00%
VUS.TOVanguard U.S. Total Market Index ETF (CAD-hedged)0.00%

About PLRX ETF Exposure

Pliant Therapeutics, Inc. (PLRX) is held by 11 exchange-traded funds, making it one of the stocks with significant ETF exposure. With a market capitalization of 82.6M, PLRX is a widely held institutional stock. The stock currently trades at $1.34. Investors can gain exposure to PLRX through a variety of ETFs with different expense ratios, investment strategies, and portfolio weightings. The table above shows all ETFs that currently hold PLRX, sorted by portfolio weight.